Skip to content
Application 207605
- Type
- ANDA
- Sponsor
- APOTEX
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | TOLVAPTAN | TOLVAPTAN | TABLET;ORAL | 30MG | No | No |
| 002 | TOLVAPTAN | TOLVAPTAN | TABLET;ORAL | 15MG | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 60505-4317 | tolvaptan | tolvaptan | Apotex Corp. | ANDA | Current |
| 60505-4317 | tolvaptan | tolvaptan | Apotex Corp. | ANDA | Current |
| 60505-4318 | tolvaptan | tolvaptan | Apotex Corp. | ANDA | Current |
| 60505-4318 | tolvaptan | tolvaptan | Apotex Corp. | ANDA | Current |
| 60505-4318 | tolvaptan | tolvaptan | Apotex Corp. | ANDA | Current |
| 60505-4318 | tolvaptan | tolvaptan | Apotex Corp. | ANDA | Current |
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 63415 | ORIG | 2020-06-04 |